SCHEMBL486755

SCHEMBL486755

CCCCCCCCCCCN(CCO)CCO

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.52
ALDH1A1 P00352 2/20 0.52
TSHR P16473 2/20 0.52
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
HSD17B10 Q99714 1/20 0.52
DNM1 Q05193 4/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
KDM5A P29375 2/20 0.43
PHF8 Q9UPP1 2/20 0.43
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA9 Q16790 1/20 0.43
KDM4C Q9H3R0 1/20 0.43
THRB P10828 2/20 0.42
GBA1 P04062 1/20 0.40
ICMT O60725 1/20 0.40
ALB P02768 1/20 0.40
HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1478275 1.00 LMNA (0.52) LMNAALDH1A1TSHRMEN1KMT2A
SCHEMBL3217339 1.00 LMNA (0.52) LMNAALDH1A1TSHRMEN1KMT2A
SCHEMBL8688351 1.00 LMNA (0.52) LMNAALDH1A1TSHRMEN1KMT2A
SCHEMBL22645993 1.00 LMNA (0.52) LMNAALDH1A1TSHRMEN1KMT2A
SCHEMBL22642596 1.00 LMNA (0.52) LMNAALDH1A1TSHRMEN1KMT2A
SCHEMBL23940310 1.00 LMNA (0.52) LMNAALDH1A1TSHRMEN1KMT2A
SCHEMBL22646107 1.00 LMNA (0.52) LMNAALDH1A1TSHRMEN1KMT2A
SCHEMBL22806624 1.00 LMNA (0.52) LMNAALDH1A1TSHRMEN1KMT2A
SCHEMBL22806605 1.00 LMNA (0.52) LMNAALDH1A1TSHRMEN1KMT2A
SCHEMBL10989638 1.00 LMNA (0.52) LMNAALDH1A1TSHRMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 458 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116023548-B External electron donor composition, application thereof, catalyst system and olefin polymerization method 中国石油化工股份有限公司 2024-10-15 CN claimed
CN-116023555-B External electron donor, application thereof, catalyst system for olefin polymerization and olefin polymerization method 中国石油化工股份有限公司 2024-08-02 CN claimed
EP-2880092-B1 PHOSPHITE COMPOSITIONS SI GROUP SWITZERLAND CHAA GMBH (CH) 2020-09-30 EP claimed
EP-2459575-B2 HYDROLYTICALLY STABLE PHOSPHITE COMPOSITIONS ADDIVANT SWITZERLAND GMBH (CH) 2018-07-25 EP claimed
EP-2621867-B1 BIOSTATIC NEUTRALIZING COMPOSITION FOR AQUEOUS FLUIDS ARKEMA FRANCE (FR) 2018-04-18 EP claimed
US-9232789-B2 Biostatic neutralizing composition for aqueous fluids ARKEMA FRANCE (FR) 2016-01-12 US claimed
EP-2880092-A1 PHOSPHITE COMPOSITIONS Addivant Switzerland GmbH (CH) 2015-06-10 EP claimed
CN-104508031-A Phosphite compositions ADDIVANT SWITZERLAND GMBH 2015-04-08 CN claimed
US-20150073073-A1 PHOSPHITE COMPOSITIONS ADDIVANT USA, LLC 2015-03-12 US claimed
CN-104387613-A Processes for forming alkylated aryl phosphite compositions from complex hydrocarbon streams CHEMTURA CORP 2015-03-04 CN claimed
EP-2459575-B1 HYDROLYTICALLY STABLE PHOSPHITE COMPOSITIONS ADDIVANT SWITZERLAND GMBH (CH) 2014-12-17 EP claimed
US-20140045981-A1 PHOSPHITE COMPOSITIONS SI GROUP, INC. 2014-02-13 US claimed
WO-2014020170-A1 PHOSPHITE COMPOSITIONS ADDIVANT SWITZERLAND GMBH (CH) 2014-02-06 WO claimed
US-20130217780-A1 Biostatic Neutralizing Composition for Aqueous Fluids ARKEMA FRANCE (FR) 2013-08-22 US claimed
EP-2621867-A1 BIOSTATIC NEUTRALIZING COMPOSITION FOR AQUEOUS FLUIDS Arkema France (FR) 2013-08-07 EP claimed
EP-2459575-A2 HYDROLYTICALLY STABLE PHOSPHITE COMPOSITIONS Chemtura Corporation (US) 2012-06-06 EP claimed
WO-2012045958-A1 BIOSTATIC NEUTRALIZING COMPOSITION FOR AQUEOUS FLUIDS ARKEMA FRANCE (FR) 2012-04-12 WO claimed
US-8048946-B2 Hydrolytically stable phosphite compositions CHEMTURA CORPORATION (US) 2011-11-01 US claimed
WO-2011014529-A2 HYDROLYTICALLY STABLE PHOSPHITE COMPOSITIONS CHEMTURA CORPORATION (US) 2011-02-03 WO claimed
US-20110028619-A1 Hydrolytically stable phosphite compositions SI GROUP, INC. 2011-02-03 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130217780-A1 Biostatic Neutralizing Composition for Aqueous Fluids MME, NEFM, COMT LMNA 4297/4885ALDH1A1 1856/4885TSHR 2477/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.